Genetics Generation Advancement Corp.

4160

TW0004160007

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
89.9 ^TWD	-1.96%		+0.33%	+131.11%

15/05	Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
25/03	Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Genetics Generation Advancement Corp. cancelled the transaction announced on March 16, 2018

March 15, 2019

On March 15, 2019, Genetics Generation Advancement Corp. (GTSM:4160) cancelled the transaction.

Latest news about Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Genetics Generation Advancement Corp. Proposes Cash Dividend for the Year Ended 31 December 2022	15/23/15	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Genetics Generation Advancement Corp. Announces Cash Dividend, Payable on September 30, 2022	15/22/15	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Genetics Generation Advancement Corp. Approves Appointment of John Chang as Chief Technical Officer	03/22/03	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31	CI
Genetics Generation Advancement Corp. Announces Cash Dividend for the Period January 1, 2021 to December 31, 2021	17/22/17	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11/21/11	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/21/13	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/21/14	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/20/12	CI
Genetics Generation Advancement Corp. Proposes Dividend Distribution, Payable on August 31, 2020	16/20/16	CI
Genetics Generation Advancement Corp. Announces Board Changes	11/20/11	CI
Genetics Generation Advancement Corp. Announces the Establishment of Audit Committee, Effective June 10, 2020	10/20/10	CI
Genetics Generation Advancement Corp. Announces Board Changes	10/20/10	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	13/20/13	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	30/20/30	CI

Chart Genetics Generation Advancement Corp.

Duration

Period

Chart Genetics Generation Advancement Corp.

More charts

Genetics Generation Advancement Corp is a Taiwan-based company principally engaged in genetic testing business. The Company mainly provides genetic testing, molecular diagnostics, biotechnology, personalized medical related testing, biological information and health care services. The Company mainly serves in the areas of maternal-fetal precision, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection and precision health management. The Company operates its businesses in domestic market and overseas markets.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
GENETICS GENERATION ADVANCEMENT CORP.	+131.11%	70.4M
EXACT SCIENCES CORPORATION	-41.97%	7.92B
GUARDANT HEALTH, INC.	+5.99%	3.51B
IOVANCE BIOTHERAPEUTICS, INC.	-4.31%	2.18B
BGI GENOMICS CO., LTD.	-21.69%	1.97B
VERACYTE, INC.	-24.94%	1.58B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+31.45%	1.14B
CAREDX, INC	+26.75%	792M
SEEGENE, INC.	-9.83%	690M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-26.33%	532M